Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colon Metastatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Large-scale testing (Phase 3)Active Not RecruitingNCT03803553
What this trial is testing

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

Who this might be right for
Metastatic Colon CancerStage III Colon Cancer
Massachusetts General Hospital 400
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Large-scale testing (Phase 3)Looking for participantsNCT04687631
What this trial is testing

Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 508
Testing effectiveness (Phase 2)Ended earlyNCT00006001
What this trial is testing

SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00034502
What this trial is testing

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Eli Lilly and Company
Early research (Phase 1)Study completedNCT03290937
What this trial is testing

Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 34
Not applicableStudy completedNCT04260139
What this trial is testing

Lymph Node Yield in Colon Cancer Resection Specimens

Who this might be right for
Colon CancerLymph Node Metastases
Bagcilar Training and Research Hospital 50
Not applicableLooking for participantsNCT06840977
What this trial is testing

COLON ERDERLY LOW DOSE

Who this might be right for
Colon Adenocarcinoma
Matteo Clavarezza 51
Testing effectiveness (Phase 2)Study completedNCT02497157
What this trial is testing

Bevacizumab + Triplet Treatment for Untreated With Chemotherapy Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 45
Large-scale testing (Phase 3)Study completedNCT01087658
What this trial is testing

Oral Glutamine in the Prevention of Oxaliplatin-induced Neurotoxicity

Who this might be right for
Colorectal Neoplasms
Sanofi 200
Testing effectiveness (Phase 2)Study completedNCT01260415
What this trial is testing

Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases

Who this might be right for
Colorectal CancerLiver Metastases
University Health Network, Toronto 11
Not applicableStudy completedNCT01830647
What this trial is testing

An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Cancer of the Colon or Rectum

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 35
Testing effectiveness (Phase 2)Ended earlyNCT01322815
What this trial is testing

A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI

Who this might be right for
Colon Cancer
Georgetown University 11
Not applicableUnknownNCT03451643
What this trial is testing

Stenting and Resection for Stage IV Colorectal Cancer Endoscopic Stenting and Colorectal Resection in Stage IV

Who this might be right for
Colorectal Neoplasm
University of Roma La Sapienza 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04599140
What this trial is testing

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+18 more
M.D. Anderson Cancer Center 51
Large-scale testing (Phase 3)Active Not RecruitingNCT04776655
What this trial is testing

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRAS Mutation
Azienda USL Reggio Emilia - IRCCS 280
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Not applicableStudy completedNCT02106858
What this trial is testing

Stivarga Regulatory Post-Marketing Surveillance Study in Korea

Who this might be right for
Colorectal Neoplasms
Bayer 316
Not applicableLooking for participantsNCT01763125
What this trial is testing

Establishment of a Tumor Bank for Blood Samples

Who this might be right for
Ovarian NeoplasmsBreast NeoplasmsColorectal Neoplasms+3 more
Medical University of Vienna 10,000
Next Page